Biopharmaceutical Product Attributes and Biological Consequences Community

 View Only
  • 1.  Webinars of Interest

    Posted 06-10-2022 09:17
    I want to share these two webinars being put on by some of our sister communities that I think will be of interest to our community as well.

    Monday, June 13, Noon to 1 pm EST
    Sponsored by the AAPS ODDB Community Seminar

    Points to consider for successful delivery of ocular gene and cell therapeutics (aka How do I inject this stuff into the eye?)
    Part 1 of a two-part seminar. 
    Speaker: Dr. Joshua Bartoe, Vice President, Ophthalmology Services, Northern Biomedical Research 
    https://meet.goto.com/883324645
    United States:  +1(646) 749-3122  Access Code: 883-324-645


    Tuesday, June 14 from 12:30 pm to 2 pm EST
    Hosted jointly by the AAPS Sterile Products and Gene and Cell Therapy Product Communities
    Developing Patient-centric Specifications for Autologous Chimeric Antigen Receptor T Cell Therapies
    Speaker: Nolan Polson, Ph.D.
    Register here Developing Patient-centric Specifications for Autologous Chimeric Antigen Receptor T Cell Therapies | AAPS
    Thank you to @Hiten Gutka@Madhushree Gokhale@Smeet Deshmukh, and AAPS staff for organizing this webinar.
    #patientcentricity #specifications #antigen #tcell #therapies #community



    ------------------------------
    Joshua Katz PhD
    Senior Principal Scientist and R&D Leader
    IFF
    Wilmington DE
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------